Brian Halak

The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania.

ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts.

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.

Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT.

Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ.

Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA.

Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.

Carticept Medical, Inc. develops and markets medical devices. It develops platform technologies to improve the safety, efficiency, and accuracy of many common injection procedures. The firm's Navigator Delivery System, a FDA-cleared computer controlled medication delivery system for intra-articular injections. The company was founded by Timothy J. Patrick and Peter J. Pizzo, III in 2005 and is headquartered in Alpharetta, GA.

Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA.

Fenway Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It provides drug development services. The company is headquartered in Newton, MA

Domain Elite Holdings Ltd. engages in the provision of investment services with interest in healthcare and medical technologies. The firm invests in medical devices, in-vitro diagnostics, and pharmaceutical products. The company was founded by Brian K. Halak and is headquartered in Beijing, China.

Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD

Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong.

SMART Medical Systems Ltd. manufactures medical devices. The firm’s products include naviaid platform, G-EYE, naviaid AB, naviaid ABC, inflation systems, controlled withdrawal nd future naviaid products. The company was founded by Gadi Terliuc in 205 and is headquartered in Ra’anana, Israel.

Kona Medical, Inc. operates as a holding company, which engages in the design and development of non-invasive therapies for the treatment of hypertension. Its proprietary technology enables the ablation of renal nerves through the use of externally-delivered ultrasound energy. The company was founded by Michael Gertner in 2009 and is headquartered in Bellevue, WA.

Zyga Technology, Inc. develops novel technology for resurfacing the facet and zygapophyseal joints. It engages in the development minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The firm offers GLYDER Facet Resurfacing System, an investigational device and is intended exclusively for clinical investigations. The company was founded by Robert Assell in March 2008 and is headquartered in Minneapolis, MN.

WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD.

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

Nobias Therapeutics, Inc. develops drugs to cure rare illnesses in children. The American company was founded by Brian K. Halak.

Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City.

Esprit Pharma, Inc. manufactures and supplies pharmaceutical products. The company offers SANCTURA, a treatment for over-active bladder and PRO-QUIN, a treatment for urinary tract infections. The company was founded in 2005 and is headquartered in East Brunswick, NJ.

SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation.